drugset / Trial / NCT06625541
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AJ302-IM in Healthy Volunteers
RandomizedSequentialDouble-blindTreatment
Summary
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of AJ302-IM following intramuscular administration of single ascending doses in healthy volunteers.
Timeline
- Start
- 2024-06-24
- Primary completion
- 2025-08-15
- Completion
- 2025-08-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AJ302-IM | Unknown | — | Intramuscular |
Indications
No indication recorded.